Sun Pharmaceutical Industries Ltd - 524715 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of 27th Annual General Meeting of Sun Pharmaceutical Industries Limited ("Company") held on August 28, 2019 pursuant to Clause 13 of Para A of Part A of Schedule Ill of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"). Sun Pharma Surges On Agreement To Sell Generic Drugs In China
Sun Pharma has entered into an agreement with China Medical System Holdings to develop and commercialize seven generic products in Mainland China. Sun Pharma announces tie-up for China foray; to develop 8 generic products
The total addressable market size for all these eight products is about $1 billion (according to recent IQVIA data) in mainland China Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed herewith our Press Release relating to licensing agreement with China Medical System Holdings for generic products in Mainland China, which we shall be releasing after sending this letter to you. This is for your information and record. Thanking you, Sun Pharma In Rs 240-Crore Licensing Pact With IICT Hyderabad
The deal is for patents related to certain compounds with potential therapeutic activity across multiple indications in Sun Pharma's specialty focus areas, the Mumbai-based pharmaceuticals... Sun Pharma inks licensing pact with CSIR-IICT, Hyderabad
To pay upfront fee of Rs 240 crore for potential development, regulatory and sales milestone SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed herewith our Press Release relating to licensing agreement with CSIR IICT, which we shall be releasing after sending this letter to you. This is for your information and record. Thanking you, SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shanghvi Finance Pvt Ltd Sun Pharmaceutical Industries Ltd - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudhir V Valia Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release relating to first quarter FY20 financials, which we shall be releasing after sending this letter to you. This is for your information and record. Thanking you,